Skip to main content

Table 1 Local therapy recurrence and mortality estimates

From: Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis

Recurrence estimates (%)

Mortality estimates (%)

ID

A!

P

(B)

P

(A)

P-A!

(B)

P-A!

(A)

A!

P

(B)

P

(A)

P-A!

(B)

P-A!

(A)

6

12

5

50

-7

38

39

5

50

-34

11

11

13

90

5

77

-8

4

10

0

6

-4

12

14

50

10

36

-4

9

30

5

21

-4

19

14

10

20

-4

6

28

10

10

-18

-18

10

15

15

20

0

5

6

10

10

4

4

3

15

10

50

-5

35

12

10

20

-2

8

20

16

30

15

14

-1

8

20

0

12

-8

5

17

15

25

-2

8

22

5

20

-17

-2

16

18

30

15

12

-3

14

30

10

16

-4

17

19

30

20

11

1

8

10

5

2

-3

2

20

95

20

75

0

9

90

0

81

-9

4

21

30

20

9

-1

15

10

20

-5

5

8

24

40

20

16

-4

13

10

10

-3

-3

18

26

30

25

4

-1

17

10

10

-7

-7

9

33

90

65

57

32

24

90

75

66

51

1

34

20

10

-14

-24

23

5

10

-18

-13

13

39

0

40

-39

1

27

0

25

-27

-2

7

40

30

40

-10

0

28

10

40

-18

12

15

53

70

70

17

17

41

70

40

29

-1

14

95

100

90

5

-5

89

100

80

11

-9

  1. This table shows the difference between patient Adjuvant! estimates, before and after the oncology visit. Patient estimates highlighted in boldface are within ± 5% of Adjuvant! Abbreviations are ID for study identification number, A! for Adjuvant!, P for patient, (B) for before the visit, and (A) for after the visit.